// App-Quantinova.ai

TCT-477 : Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

Researchers

Presenter

  • Christian Dworeck

Principal Investigators

  • Oscar Angeras

  • Inger Haraldsson

  • Dan Ioanes

  • Jacob Odenstedt

  • Petur Petursson

  • Lotta Robertsson

  • Jason Stewart

  • Sebastian Volz

  • Per Albertsson

  • Truls Ramunddal

Medical Centers

  • Cardiology, Skovde, Sweden

  • Hospital, Trollhattan, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Unknown, Goteborg, Sweden

  • Sahlgrenska Sweden, Viken, Sweden

  • University of Verona, Gothenburg, Sweden

  • Department of Cardiology, Hisings Backa, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Boras Hospital, Boras, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Restenosis

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved